A new class of anti-cancer drugs have been developed, bringing new hope to humanity. More so for those with advanced or spreading lung and pancreatic cancer.
As reported in Science Alert, cancer biologist Dr Adam Patterson said, "Our experiments show that this new prodrug is much more active than the current gold-standard drug treatment for advanced or spreading lung and pancreatic cancer. It’s very common for tumours to start re-growing after you stop administering this type of cancer drug. But after we stopped doses of this prodrug, the tumours still hadn’t re-grown 30 days later. The prodrug appears to act like slow-release chemotherapy.”
Dr Adam Patterson and medicinal chemist Dr Jeffrey Smaill, investigators with the Maurice Wilkins Centre for Molecular Biodiscovery, made the discovery after a decade of work on the prodrug.
Read more here.
No comments:
Post a Comment